Upgrade to SI Premium - Free Trial

Teladoc (TDOC) PT Raised to $27 at Oppenheimer Following 4Q Report

March 2, 2017 9:22 AM
Oppenheimer raised its price target on Teladoc (NYSE: TDOC) to $27.00 (from $23.00) while maintaining a Outperform rating. TDOC reported ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles